ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 7600 iu / 0.8 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - sodium chloride 9 mg/ml - solution for infusion - sodium chloride - vehicle or diluent for parenteral administration of medicines for intravenous, intramuscular or subcutaneous route.

ישראל - עברית - Ministry of Health

cure medical & technical supply - acetic acid 5.6 ml/l; arginine 8.4 g/l - solution for infusion - amino acids - vamin 14ef is indicated as a source of amino acids for protein synthesis in patients needing intravenous nutrition. vamin 14ef is particulary suitable for patients with moderaterly increased amino acid requirements.

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited - paracetamol 10 mg/ml - solution for infusion - anilides - perfalgan is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever, when administration by intravenous route is clinically justified by and urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.25 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.5 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - tezepelumab - תמיסה להזרקה - tezepelumab 110 mg/ml - tezepelumab